Literature DB >> 15002631

How much should Medicare pay for drugs?

Joseph P Newhouse1.   

Abstract

Discussions of the Medicare drug benefit have focused more on what beneficiaries will pay than what pharmaceutical manufacturers will receive. A key choice is the degree to which Medicare must become involved in setting manufacturers' prices. If prices must be set, Medicare could do so using average wholesale price, comparison with prices in other markets, cost, or rate-of-return regulation. Because all four methods have substantial drawbacks, Medicare should not initially attempt to set prices, but to prevent abuses in pricing, Congress should allow cost to be considered in coverage decisions.

Mesh:

Year:  2004        PMID: 15002631     DOI: 10.1377/hlthaff.23.1.89

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  3 in total

Review 1.  Principles of pharmacoeconomics and their impact on strategic imperatives of pharmaceutical research and development.

Authors:  József Bodrogi; Zoltán Kaló
Journal:  Br J Pharmacol       Date:  2010-02-02       Impact factor: 8.739

2.  What is in your wallet? A cluster randomized trial of the effects of showing comparative patient out-of-pocket costs on primary care prescribing for uncomplicated hypertension.

Authors:  Robyn Tamblyn; Nancy Winslade; Christina J Qian; Teresa Moraga; Allen Huang
Journal:  Implement Sci       Date:  2018-01-10       Impact factor: 7.327

Review 3.  Value-Based Pricing and Reimbursement in Personalised Healthcare: Introduction to the Basic Health Economics.

Authors:  Louis P Garrison; Adrian Towse
Journal:  J Pers Med       Date:  2017-09-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.